NYSE:DHRLife Sciences
Is It Time To Reassess Danaher (DHR) After Recent Share Price Weakness?
If you are wondering whether Danaher is starting to look attractively priced or still has more room to fall, its recent share performance and valuation checklist provide a useful starting point.
The stock last closed at US$198.80, with returns of a 3.5% decline over 7 days, 8.2% decline over 30 days, 13.7% decline year to date, 2.5% decline over 1 year, 5.3% decline over 3 years, and a 5.6% gain over 5 years.
Recent coverage has focused on Danaher as a large US healthcare and life sciences...